ATE138976T1 - Nachweisverfahren für den totalgehalt an gonadotropen alpha-peptidketten - Google Patents

Nachweisverfahren für den totalgehalt an gonadotropen alpha-peptidketten

Info

Publication number
ATE138976T1
ATE138976T1 AT91907306T AT91907306T ATE138976T1 AT E138976 T1 ATE138976 T1 AT E138976T1 AT 91907306 T AT91907306 T AT 91907306T AT 91907306 T AT91907306 T AT 91907306T AT E138976 T1 ATE138976 T1 AT E138976T1
Authority
AT
Austria
Prior art keywords
gonadotropic
detection method
total content
peptide chains
alpha peptide
Prior art date
Application number
AT91907306T
Other languages
English (en)
Inventor
Kathleen M Clough
Francis X Cole
Original Assignee
Hygeia Sciences Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hygeia Sciences Ltd filed Critical Hygeia Sciences Ltd
Application granted granted Critical
Publication of ATE138976T1 publication Critical patent/ATE138976T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/76—Human chorionic gonadotropin including luteinising hormone, follicle stimulating hormone, thyroid stimulating hormone or their receptors
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function
    • Y10S436/814—Pregnancy
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/815—Test for named compound or class of compounds
    • Y10S436/817—Steroids or hormones
    • Y10S436/818—Human chorionic gonadotropin
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/906—Fertility tests

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Reproductive Health (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)
  • Silicon Polymers (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
AT91907306T 1990-04-05 1991-03-29 Nachweisverfahren für den totalgehalt an gonadotropen alpha-peptidketten ATE138976T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/505,307 US5366863A (en) 1990-04-05 1990-04-05 Total gonadotropal alpha peptide chain assay

Publications (1)

Publication Number Publication Date
ATE138976T1 true ATE138976T1 (de) 1996-06-15

Family

ID=24009799

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91907306T ATE138976T1 (de) 1990-04-05 1991-03-29 Nachweisverfahren für den totalgehalt an gonadotropen alpha-peptidketten

Country Status (13)

Country Link
US (1) US5366863A (de)
EP (1) EP0537154B1 (de)
JP (1) JP2550454B2 (de)
AT (1) ATE138976T1 (de)
AU (1) AU652150B2 (de)
CA (1) CA2078861C (de)
DE (1) DE69120073T2 (de)
DK (1) DK0537154T3 (de)
ES (1) ES2089207T3 (de)
GR (1) GR3020965T3 (de)
IE (1) IE911149A1 (de)
NZ (1) NZ237706A (de)
WO (1) WO1991015594A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9217864D0 (en) 1992-08-21 1992-10-07 Unilever Plc Monitoring method
GB9217808D0 (en) * 1992-08-21 1992-10-07 Unilever Plc Advisory method
US7141212B2 (en) 1993-11-12 2006-11-28 Inverness Medical Switzerland Gmbh Reading devices and assay devices for use therewith
DE69626016T2 (de) 1996-09-27 2004-01-08 Inverness Medical Switzerland Gmbh Test-Kit und Vorrichtungen
JP2001349892A (ja) * 2000-04-03 2001-12-21 Unilever Nv 検査方法及びデバイス
US8828329B2 (en) 2010-10-01 2014-09-09 Church & Dwight, Co., Inc. Electronic analyte assaying device

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4196123A (en) * 1978-11-20 1980-04-01 Eugenia Rosemberg Hybrid chorionic gonadotropin preparations and methods for stimulating ovulation using same
US4514505A (en) * 1982-05-21 1985-04-30 The Trustees Of Columbia University In The City Of New York Monoclonal antibody mixtures and use thereof for enhanced sensitivity immunoassays
US4659678A (en) * 1982-09-29 1987-04-21 Serono Diagnostics Limited Immunoassay of antigens

Also Published As

Publication number Publication date
DK0537154T3 (da) 1996-10-14
EP0537154A4 (en) 1993-11-18
EP0537154B1 (de) 1996-06-05
ES2089207T3 (es) 1996-10-01
IE911149A1 (en) 1991-10-09
DE69120073D1 (de) 1996-07-11
WO1991015594A1 (en) 1991-10-17
GR3020965T3 (en) 1996-12-31
US5366863A (en) 1994-11-22
EP0537154A1 (de) 1993-04-21
JP2550454B2 (ja) 1996-11-06
JPH05509393A (ja) 1993-12-22
CA2078861C (en) 1999-06-08
CA2078861A1 (en) 1991-10-06
AU652150B2 (en) 1994-08-18
NZ237706A (en) 1992-11-25
AU7556191A (en) 1991-10-30
DE69120073T2 (de) 1996-11-07

Similar Documents

Publication Publication Date Title
DE69521608D1 (de) Verwendung von humanem neutrophil-lipocalin(hnl) als diagnostischer marker und anti-hnl-antikörperzubereitung
IT8822206A0 (it) Dispositivo e metodo per la diagnosi di gravidanza
NL980030I2 (nl) Combinatie van angiotensineomzetting-enzym-remmersmet calciumantagonisten alsmede de toepassing daarvan in medicijnen.
NO890071D0 (no) Nedbrytningsanalyse for kollagen type iii.
ES2169179T3 (es) Metodo consultivo.
FR2600709B1 (fr) Dispositif et methode de mise en place et de connexion d'un raccord coude
NO953770L (no) Analysemetode
BR8506817A (pt) Glicoproteina antigenica bovina,anticorpo relacionado e uso na deteccao de gravidez no gado
DK0648335T3 (da) Diagnostisk fremgangsmåde til bestemmelse af fødselstilbøjeligheden og reagenskit til anvendelse dertil
DE69120073D1 (de) Nachweisverfahren für den totalgehalt an gonadotropen alpha-peptidketten
GB8417338D0 (en) Human proteins antisera and test kits
FI953093L (fi) Menetelmiä, joilla voidaan havaita ja hoitaa yksilöitä, joilla on epänormaaleja soluja, jotka ekspressoivat HLA-A2/tyrosinaasi-peptidiantigeenejä
ATE108025T1 (de) Menschliches igg glykosylation-bestimmung.
IT8423926A0 (it) Metodo diagnostico per la valutazione di parametri clinici mediante prelievo diretto dimateriali biologici e dispositivoper la sua attuazione.
NZ306622A (en) Method for diagnosing a patient for chlamydia
DK164464C (da) Fremgangsmaade til analyse af polyelektrolytter, hvorved man bestemmer graden af kaedeforgrening og tvaerbinding i polyelektrolytterne
NO963911D0 (no) Innretning for behandling av autoimmune sykdommer og fremgangsmåte for behandling
ES2056872T3 (es) Proteina pp4-x anticoagulante, su preparacion y empleo.
AU2952489A (en) Method of determining human acid glutathione S-transferase, reagent therefor, kit therefor, method of diagnosing cancer in digestive organs, and monoclonal antibody for use therein
NO873282D0 (no) Motordrevet ventilanalyse- og testesystem.
NO157437C (no) Proeveinnretning for bestemmelse av blod i faeces.
IT8622049A0 (it) Metodo per la determinazione dell'attivita' biologica della proteina c nel plasma umano, e relativi reagenti.
NO885511D0 (no) Fremgangsmaate og innretning for enkeltbestemmelsesblodanalyse.
DK159458C (da) Tripeptid-p-nitroanilider og anvendelse deraf til kvantitativ analyse for proteolytiske enzymer
NO895007D0 (no) Simultan enzym-immunoanalyse for deteksjon av antigen og/eller antistoff i mennesker.